Health ❯Medical Conditions ❯Neurological Disorders ❯Dementia
New research highlights the potential of combining blood-based biomarkers with cognitive and imaging tools to identify Alzheimer’s risk before symptoms appear, particularly in high-risk and underrepresented populations.